Vissers M C, Fantone J C
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109.
Free Radic Biol Med. 1990;8(4):331-7. doi: 10.1016/0891-5849(90)90098-4.
Inhibition of free radical mechanisms by desferrioxamine, an iron chelator, is often thought to be a good indicator of iron-catalyzed hydroxyl radical (OH.) production. The specificity of desferrioxamine is critical for such identification. This study was undertaken to determine whether desferrioxamine could prevent the in vitro cytotoxic reactions of hypochlorous acid (HOCl), a major neutrophil-derived oxidant. Red blood cells were used as a target for HOCl, and cell lysis and haemoglobin oxidation were measured. Desferrioxamine, and its iron-chelated form, ferrioxamine, were shown to prevent both effects of HOCl. However, desferrioxamine was 6 to 8 times more efficient than either ferrioxamine or taurine, another amine which prevents HOCl-mediated cell lysis, in preventing both lysis and Hb oxidation. After reaction with HOCl, ferrioxamine and taurine retained almost all the oxidizing equivalents as long-lived chloramine. However, with desferrioxamine less than half the oxidizing equivalents were recovered as chloramines indicating that sites other than the terminal amine reacted with HOCl. The chloramines formed were able to oxidize molecules in solution, but being hydrophilic they were confined to the extracellular medium and cell lysis did not occur. The results indicate that scavenging of HOCl could be a factor in the inhibition by desferrioxamine of neutrophil-mediated cell lysis in vitro.
去铁胺(一种铁螯合剂)对自由基机制的抑制作用常被认为是铁催化产生羟基自由基(OH.)的良好指标。去铁胺的特异性对于这种识别至关重要。本研究旨在确定去铁胺是否能预防次氯酸(HOCl,一种主要由中性粒细胞产生的氧化剂)在体外的细胞毒性反应。红细胞被用作HOCl的作用靶点,并检测细胞裂解和血红蛋白氧化情况。结果表明,去铁胺及其铁螯合形式(铁胺)均可预防HOCl的这两种效应。然而,在预防细胞裂解和血红蛋白氧化方面,去铁胺的效率比铁胺或牛磺酸(另一种可预防HOCl介导的细胞裂解的胺类)高6至8倍。与HOCl反应后,铁胺和牛磺酸几乎保留了所有的氧化当量,形成了长寿命的氯胺。然而,对于去铁胺,作为氯胺回收的氧化当量不到一半,这表明除末端胺基外的其他位点也与HOCl发生了反应。形成的氯胺能够氧化溶液中的分子,但由于它们具有亲水性,被限制在细胞外介质中,因而不会发生细胞裂解。结果表明,清除HOCl可能是去铁胺在体外抑制中性粒细胞介导的细胞裂解的一个因素。